​

Why NullGraph

The scientific community has a hidden crisis: 95% of null results never see the light of day. This isn’t a minor inefficiency — it’s a systemic failure that distorts science, wastes billions in research funding, and slows medical breakthroughs.

​

The publication bias crisis

​

The 95% problem

When researchers run experiments that produce negative or null results — experiments that disprove a hypothesis or find no significant effect — those results overwhelmingly go unpublished. Journals favor positive findings, and researchers have no career incentive to document failures. This creates four cascading problems:

​

1. Publication bias

Journals overwhelmingly favor positive results, creating a distorted scientific record. When only successful experiments are published, the literature overstates the efficacy of treatments, the strength of correlations, and the reproducibility of findings. Real-world impact:

• Meta-analyses become unreliable
• Drug efficacy appears higher than reality
• Failed approaches appear unexplored

​

2. Wasted replication

Researchers unknowingly repeat experiments that have already been proven to fail. Without access to negative results, labs around the world duplicate dead-end approaches. The cost:

• Billions in research funding spent re-failing
• Years of researcher time on known-bad paths
• Opportunity cost of experiments not run

​

3. Lost investment

Research institutions, pharmaceutical companies, and public funding agencies invest heavily in experiments. When those experiments produce null results, the investment produces zero public value — the data sits in filing cabinets or on local hard drives. The waste:

• Public funding produces private knowledge
• Institutional knowledge dies when researchers leave
• No return on investment for failed experiments

​

4. Zero incentive

Researchers have no career, financial, or reputational reason to publish negative findings:

• No journal will accept it (or only low-tier journals)
• No citations or h-index boost
• No grant reviewers care about your failures
• No promotion committees reward documenting dead ends

The current system actively punishes researchers for doing the right thing.

​

How NullGraph solves this

NullGraph creates economic incentives for sharing null results by making them permanent, discoverable, and valuable.

​

Permanence: On-chain Null Knowledge Assets

Every null result becomes a Null Knowledge Asset (NKA) — a permanent, immutable record stored on Solana. NKAs include:

• Full experimental metadata (hypothesis, methodology, outcomes)
• Statistical rigor (p-value, sample size)
• Data provenance (SHA-256 hash linking to off-chain datasets)
• Researcher attribution (wallet address)

Once minted, an NKA exists forever. It can’t be taken down, edited retroactively, or lost when a lab closes.

​

Discoverability: Dashboard and registry

All NKAs are instantly searchable through the NullGraph Dashboard. Researchers and BioDAOs can:

• Browse the full NKA registry
• Filter by researcher, date, or statistical significance
• Link directly to Solana Explorer for on-chain verification
• Access full experimental details

No paywalls, no journal subscriptions, no access restrictions.

​

Value: Bounty marketplace

NullGraph creates a two-sided marketplace where: Demand side (BioDAOs, pharma, researchers):

• Post bounties describing specific null results they need
• Escrow BIO tokens as rewards
• Review submissions and approve matching NKAs

Supply side (researchers):

• Submit NKAs to matching bounties
• Receive BIO token payouts on approval (97.5% after protocol fee)
• Build reputation through successful bounty fulfillments

​

Economic alignment

For the first time, researchers have a financial reason to document and share negative results:

1. Direct compensation through bounty payouts
2. Reputational credit through on-chain attribution
3. Future optionality — NKAs minted today can match bounties posted months later
4. Public good incentive — protocol fees fund ongoing development

​

Real-world use cases

​

BioDAO knowledge acquisition

A longevity-focused BioDAO needs to know which senolytic compounds have already been tested and failed in mouse models. Instead of funding duplicate experiments, they post a 10,000 BIO bounty for null results on specific compounds. Result: Instant access to failed experiments, saving months and $500K in lab costs.

​

Pharmaceutical due diligence

A biotech company is considering licensing a drug candidate. Before committing, they post bounties for any null results on related mechanisms of action. Result: Risk mitigation through access to negative data that would never appear in journals.

​

Academic meta-analysis

A research group conducting a systematic review needs unpublished negative trials to correct for publication bias. They post bounties for null RCT results in their domain. Result: More accurate meta-analyses reflecting true effect sizes, not just published successes.

​

Lab knowledge transfer

A PI retires and their lab’s unpublished negative results would be lost forever. Before closing, they mint NKAs for all failed experiments. Result: Institutional knowledge preserved on-chain, available for future researchers.

​

Why Solana + BIO tokens?

​

Solana: Speed and cost

• Sub-second finality — NKAs appear instantly
• Low transaction fees — minting an NKA costs ~$0.00025
• High throughput — scales to millions of NKAs
• Composability — other protocols can build on NullGraph

​

BIO tokens: Aligned incentives

• Shared ecosystem with Bio Protocol’s DeSci infrastructure
• Liquidity — researchers can immediately convert payouts
• Governance potential — future DAO participation
• Network effects — more BioDAOs using BIO = more bounty demand

​

The path forward

NullGraph doesn’t just solve publication bias — it creates a new primitive for scientific knowledge. Null Knowledge Assets are:

• Programmable — smart contracts can reference and reward NKAs
• Composable — other protocols can index, verify, or aggregate NKAs
• Tradeable (future) — NKAs could have secondary markets for high-value negative results
• Verifiable — decentralized verification networks could stake on NKA validity

​

Future enhancements

• BioDAO-funded bounties — DAOs programmatically funding bounties via governance
• Knowledge graph indexing — decentralized indexers building NKA relationship graphs
• Community verification — reputation-weighted validation of NKA claims (Pending → Verified → Disputed status transitions)
• NFT extensions — NKAs as tradeable knowledge assets with royalty splits

​

The bottom line

Science produces two kinds of results: discoveries and non-discoveries. Journals only publish one. NullGraph publishes both. By making null results permanent, discoverable, and economically valuable, NullGraph fixes the 95% problem and creates a more honest, efficient scientific ecosystem.